Protective effect of amlodipine on rat bone tissue after orchidectomy

Pharmacology. 2012;89(1-2):37-43. doi: 10.1159/000335491. Epub 2012 Feb 1.

Abstract

Aim: Our study aimed to investigate the effect of amlodipine on bone metabolism in orchidectomized rats.

Methods: Eight-week-old rats were divided into three groups. The sham-operated control group (SHAM) and the control group after orchidectomy (ORX) received the standard laboratory diet (SLD). The experimental group after orchidectomy (ORX+AML) received SLD enriched with amlodipine for 12 weeks. Bone marker concentrations in serum of PINP, OPG and IGF-1, and the levels of CTX-I, BAP and BMP-2 in a bone homogenate were measured using enzyme-linked immunosorbent assay. Bone mineral density (BMD) was measured by dual energy X-ray absorptiometry. The femurs were used for biomechanical testing.

Results: Bone markers (CTX-I, BAP, BMP-2) in ORX were higher versus SHAM. In ORX+AML there was a decrease in PINP, CTX-I, BAP, BMP-2 and OPG versus ORX. IGF-1 was decreased in ORX versus SHAM. In ORX+AML it was increased versus ORX. In ORX, a decrease was demonstrated versus SHAM in BMD of the whole body, in the lumbar vertebrae and in both femurs. In ORX+AML there was an increase in BMD of the whole body versus ORX. Three-point bending test revealed a decrease in maximal load values in ORX versus SHAM. After amlodipine administration there was an increase in the left femur versus ORX.

Conclusions: Amlodipine is capable of mitigating the negative effects of orchidectomy and could be a good prevention of osteoporosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alkaline Phosphatase / metabolism
  • Amlodipine / pharmacology
  • Amlodipine / therapeutic use*
  • Animals
  • Biomarkers / blood
  • Biomechanical Phenomena / physiology
  • Bone Density / drug effects
  • Bone Morphogenetic Protein 2 / metabolism
  • Bone and Bones / drug effects
  • Bone and Bones / metabolism*
  • Calcium Channel Blockers / pharmacology
  • Calcium Channel Blockers / therapeutic use
  • Collagen Type I / metabolism
  • Disease Models, Animal
  • Insulin-Like Growth Factor I / metabolism*
  • Male
  • Orchiectomy / adverse effects*
  • Osteoporosis / drug therapy
  • Osteoporosis / physiopathology
  • Osteoporosis / prevention & control*
  • Osteoprotegerin / blood*
  • Peptide Fragments / blood*
  • Procollagen / blood*
  • Rats
  • Rats, Wistar

Substances

  • Biomarkers
  • Bone Morphogenetic Protein 2
  • Calcium Channel Blockers
  • Collagen Type I
  • Osteoprotegerin
  • Peptide Fragments
  • Procollagen
  • procollagen Type I N-terminal peptide
  • Amlodipine
  • Insulin-Like Growth Factor I
  • Alkaline Phosphatase